Price to Sales ratio Analysis of BioCryst Pharmaceuticals Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
3.73
Period Ending - Dec-22
Very Poor PS
4.08
Growth
-8.49 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
3.43
PS Analysis of BioCryst Pharmaceuticals Inc
P/S Ratio of BioCryst Pharmaceuticals Inc with value of 3.43 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of BCRX has fallen by -8.49 % Compared to previous Financial Year. |
PS Ratio with value of 57.94 was highest in Year Dec-20 in last Five Years. |
PS Ratio of BCRX trending down for at least three Years. |
Latest PS Ratio with value of 3.73 is lower than Average PS of 17.48 in last five years. |
Other PS Related Info of BCRX that may interest you.
BioCryst Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
BCRX | 6.17 | 6.23 | 0.963 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..![Price to Sales Formula Price to Sales Formula](https://my.stockaio.com/help/template/FinDef/ValuationRatios/PriceToSales.jpg)
PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of BioCryst Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 3.73 | 4.08 | 7.03 | 57.94 | 14.61 | 30.83 | 20.69 |
Change | -8.49 % | -41.97 % | -87.86 % | 296.71 % | -52.62 % | 49.00 % | 19.90 % |
FY Chart of Price to Sales of BioCryst Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)